The covalent attachment of one or multiple heme cofactors to cytochrome c protein chains enables cytochrome c proteins to be used in electron transfer and redox catalysis in extracytoplasmic environments. A dedicated heme maturation machinery, whose core component is a heme lyase, scans nascent peptides after Sec-dependent translocation for CXCH-binding motifs. Here we report the three-dimensional (3D) structure of the heme lyase CcmF, a 643-amino acid integral membrane protein, from Thermus thermophilus. CcmF contains a heme b cofactor at the bottom of a large cavity that opens toward the extracellular side to receive heme groups from the heme chaperone CcmE for cytochrome maturation. A surface groove on CcmF may guide the extended apoprotein to heme attachment at or near a loop containing the functionally essential WXWD motif, which is situated above the putative cofactor binding pocket. The structure suggests heme delivery from within the membrane, redefining the role of the chaperone CcmE.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611092PMC
http://dx.doi.org/10.1038/s41589-021-00793-8DOI Listing

Publication Analysis

Top Keywords

heme lyase
12
heme
10
lyase ccmf
8
chaperone ccme
8
architecture membrane-bound
4
cytochrome
4
membrane-bound cytochrome
4
cytochrome heme
4
ccmf
4
ccmf covalent
4

Similar Publications

Different sensitivities of porcine coronary arteries and veins to BAY 60-2770, a soluble guanylate cyclase activator.

J Pharmacol Sci

January 2025

Department of Pathological and Molecular Pharmacology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569-1094, Japan.

Nitric oxide (NO)-donor drugs, which stimulate reduced form of soluble guanylate cyclase (sGC), have different efficacy to the arteries and veins. This study examined whether sGC activators, which activate oxidized/apo sGC, also have arteriovenous selectivity similar to that of NO-donor drugs. The mechanical responses of the isolated blood vessels were assessed using the organ chamber technique and protein expression was verified using western blotting.

View Article and Find Full Text PDF

The porphyrias are a group of disorders of heme biosynthesis, each characterized by an enzymatic defect in the heme biosynthetic pathway. Porphyria cutanea tarda (PCT) arises due to the inhibition of uroporphyrinogen decarboxylase (UROD) in the presence of hepatic iron and oxidative stress. Most patients with PCT have evidence of siderosis on liver biopsy, and the disease resolves with iron depletion.

View Article and Find Full Text PDF

The acute hepatic porphyrias (AHPs) are a family of rare genetic diseases associated with attacks of abdominal pain, vomiting, weakness, neuropathy, and other neurovisceral symptoms. Pathogenic variants in 1 of 4 enzymes of heme synthesis are necessary for the development of AHP, and the onset of acute attacks also requires the induction of δ-aminolevulinic acid synthase 1 (ALAS1), the first and rate-limiting step of heme synthesis in the liver. Givosiran is an RNA interference medication that inhibits hepatic ALAS1 and was designed to treat AHP.

View Article and Find Full Text PDF

Controlling the trans effect induced by nitric oxide and carbon monoxide: H93C myoglobin versus H-NOX sensors and soluble guanylate cyclase.

Protein Sci

December 2024

Laboratoire d'Optique et Biosciences, INSERM U-1182, CNRS UMR 7645, Ecole Polytechnique, Palaiseau, France.

Article Synopsis
  • - Myoglobin was genetically modified by replacing histidine (His93) with cysteine to study how diatomic ligands like carbon monoxide (CO) and nitric oxide (NO) affect bonding and dynamics, using advanced spectroscopy techniques.
  • - This mutation resulted in altered heme bonding and dynamics, which showed different behavior compared to the wild-type myoglobin but paralleled observations in soluble guanylate cyclase (sGC), particularly in how NO and CO interact.
  • - The study found that after light-induced dissociation, NO quickly recombined with the modified myoglobin, showing unique dynamic behaviors including rapid CO rebinding that had not been observed in other myoglobin mutants, suggesting a novel activation mechanism for sGC in the presence
View Article and Find Full Text PDF

Expression of soluble guanylate cyclase (sGC) and its ability to form a functional heterodimer are crucial for reviving the NO-sGC signaling in PAH.

Free Radic Biol Med

November 2024

Department of Inflammation and Immunity, Lerner Research Institute, The Cleveland Clinic, Cleveland, OH, 44196, USA. Electronic address:

In order to determine the underpinnings of a dysfunctional NO-sGC signal pathway which occurs in pulmonary arterial hypertension (PAH), we investigated pulmonary arterial smooth muscle cells (PASMCs) derived from PAH patients. We found low expression of sGC, a poor sGCα1β1 heterodimer and this correlated with low expression of its facilitator chaperon, hsp90. Treating PASMCs overnight (16 h) with low micromolar doses of a slow release NO donor DETANONOate, reinstated the sGCα1β1 heterodimer and restored its NO-heme dependent activity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!